Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study

Type B insulin resistance (TBIR) is an extremely rare disease characterized by marked hyperglycemia and insulin resistance and often coexists with autoimmune diseases. The characteristics, symptoms, blood glucose patterns, comorbidities, and treatments of TBIR all vary and are not defined. In this s...

Full description

Saved in:
Bibliographic Details
Main Authors: Yusuke Hirota, Hirotsugu Suwanai, Toshimasa Yamauchi, Takashi Kadowaki
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2020/4359787
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849683117732790272
author Yusuke Hirota
Hirotsugu Suwanai
Toshimasa Yamauchi
Takashi Kadowaki
author_facet Yusuke Hirota
Hirotsugu Suwanai
Toshimasa Yamauchi
Takashi Kadowaki
author_sort Yusuke Hirota
collection DOAJ
description Type B insulin resistance (TBIR) is an extremely rare disease characterized by marked hyperglycemia and insulin resistance and often coexists with autoimmune diseases. The characteristics, symptoms, blood glucose patterns, comorbidities, and treatments of TBIR all vary and are not defined. In this study, we described a case of TBIR that developed 6 months after DPP-4 inhibitor administration and immediately after the patient caught a cold. Treatment using prednisolone and insulin-like growth factor-1 was effective. We also conducted an observational survey-based case series study in a Japanese cohort comprising 21 cases. The average age of onset of TBIR was 62.3±14.8 (17–84) years, and 61.9% of subjects were male. The majority of patients (90.4%) were 50 years old and over. During the study period, there was a high percentage (85.7%) of episodes of hypoglycemia, which was the trigger for diagnosis in more than 50% of cases. Glycemic patterns included 7 cases of hyperglycemia (33.3%), 10 cases of hypoglycemia (47.6%), and 4 cases of both hyperglycemia and hypoglycemia (19.1%). In the hypoglycemic group, 90.0% of patients were male. Furthermore, 71.4% of cases were antinuclear antibody positive, and 81.0% of cases were complicated with autoimmune disease. Systemic lupus erythematosus (38.1%) and Sjögren’s syndrome (23.8%) were relatively common as coexisting autoimmune diseases. Treatment was based on prednisolone use, which was used in 88.9% of patients. On the other hand, the effect of IGF-1 was limited. Overall, the prognosis of TBIR was good.
format Article
id doaj-art-d1b9e01082284d4ea91bbd8f91674c19
institution DOAJ
issn 2314-6745
2314-6753
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-d1b9e01082284d4ea91bbd8f91674c192025-08-20T03:23:59ZengWileyJournal of Diabetes Research2314-67452314-67532020-01-01202010.1155/2020/43597874359787Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series StudyYusuke Hirota0Hirotsugu Suwanai1Toshimasa Yamauchi2Takashi Kadowaki3Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, JapanDepartment of Diabetes, Metabolism and Endocrinology, Tokyo Medical University, Tokyo 160-0023, JapanDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, JapanDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8655, JapanType B insulin resistance (TBIR) is an extremely rare disease characterized by marked hyperglycemia and insulin resistance and often coexists with autoimmune diseases. The characteristics, symptoms, blood glucose patterns, comorbidities, and treatments of TBIR all vary and are not defined. In this study, we described a case of TBIR that developed 6 months after DPP-4 inhibitor administration and immediately after the patient caught a cold. Treatment using prednisolone and insulin-like growth factor-1 was effective. We also conducted an observational survey-based case series study in a Japanese cohort comprising 21 cases. The average age of onset of TBIR was 62.3±14.8 (17–84) years, and 61.9% of subjects were male. The majority of patients (90.4%) were 50 years old and over. During the study period, there was a high percentage (85.7%) of episodes of hypoglycemia, which was the trigger for diagnosis in more than 50% of cases. Glycemic patterns included 7 cases of hyperglycemia (33.3%), 10 cases of hypoglycemia (47.6%), and 4 cases of both hyperglycemia and hypoglycemia (19.1%). In the hypoglycemic group, 90.0% of patients were male. Furthermore, 71.4% of cases were antinuclear antibody positive, and 81.0% of cases were complicated with autoimmune disease. Systemic lupus erythematosus (38.1%) and Sjögren’s syndrome (23.8%) were relatively common as coexisting autoimmune diseases. Treatment was based on prednisolone use, which was used in 88.9% of patients. On the other hand, the effect of IGF-1 was limited. Overall, the prognosis of TBIR was good.http://dx.doi.org/10.1155/2020/4359787
spellingShingle Yusuke Hirota
Hirotsugu Suwanai
Toshimasa Yamauchi
Takashi Kadowaki
Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study
Journal of Diabetes Research
title Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study
title_full Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study
title_fullStr Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study
title_full_unstemmed Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study
title_short Clinical Features of Type B Insulin Resistance in Japanese Patients: Case Report and Survey-Based Case Series Study
title_sort clinical features of type b insulin resistance in japanese patients case report and survey based case series study
url http://dx.doi.org/10.1155/2020/4359787
work_keys_str_mv AT yusukehirota clinicalfeaturesoftypebinsulinresistanceinjapanesepatientscasereportandsurveybasedcaseseriesstudy
AT hirotsugusuwanai clinicalfeaturesoftypebinsulinresistanceinjapanesepatientscasereportandsurveybasedcaseseriesstudy
AT toshimasayamauchi clinicalfeaturesoftypebinsulinresistanceinjapanesepatientscasereportandsurveybasedcaseseriesstudy
AT takashikadowaki clinicalfeaturesoftypebinsulinresistanceinjapanesepatientscasereportandsurveybasedcaseseriesstudy